Abstract: Background: Stevens-Johnson syndrome and toxic epidermal necrolysis are life-threatening blistering drug reactions with high incidence of ocular sequela. The term 'Epidermal Necrolysis' has been recently used to better describe the full spectrum of the disease that includes Stevens-Johnson syndrome and toxic epidermal necrolysis at opposite ends, which differ by the extent of body surface area with epidermal detachment. SCORTEN is a mortality prognosis score for 'Epidermal Necrolysis' cases that still needed validation in acquired immunodeficiency syndrome. oBjective: To evaluate the SCORTEN performance in acquired immunodeficiency syndrome, and the differences in outcomes between acquired immunodeficiency syndrome and non-acquired immunodeficiency syndrome cohorts. Methods: Retrospective cohort study of AIDS and non-AIDS 'Epidermal Necrolysis' cases admitted to a Brazilian reference center from 1990-2014. results: Five deaths (16.7%) occurred as a consequence of EN in 30 AIDS patients, and seven (17.9%) in 39 non-AIDS patients, relative risk (RR) .92 (p=1.0). SCORTEN showed great performance, with an Area Under the Receiver Operating Curve (AUC) (ROC) of 0.90 with a 95% confidence interval ranging from .81 to .99. The performance of SCORTEN was better among non-AIDS patients than AIDS patients: AUC non-acquired immunodeficiency syndrome =0.99 (CI 05% 0.96-1.00), AUC acquired immunodeficiency syndrome = 0.74 (CI 95% 0.53-0.95), p=.02. study liMitations: Heterogeneity of cases, wide variation of systemic corticosteroid doses when used. conclusion: SCORTEN is valid for the Brazilian population, including among those patients with acquired immunodeficiency syndrome, and, as such, its use is recommended for aiding treatment choice in this subgroup of patients.
The term 'Epidermal Necrolysis' (EN) has been recently used to better describe the full spectrum of disease that includes SJS and TEN at opposite ends, which differ only by the percentage of body surface area of epidermal detachment (SJS<10% and TEN>30%), and, therefore, by severity. 3 Data suggest that the pathogenesis of EN is mediated by medication-induced cytotoxic response by T-cells triggered by drugs, which results in keratinocyte apoptosis, possibly due to modifications in major histocompatibility complex I proteins by non-covalent binding of the offending drug to specific human leucocyte antigens (HLA), leading to CD8+ T-cell activation. [3] [4] [5] Despite being rare, this disease presents high lethality (12-46%) , and high morbidity, with generalized infections, sepsis, and disseminated intravascular coagulation as the major acute adverse events, and ocular scars as main chronic sequela. 3, 6, 7 The severity of such events imposes the significance of adequate management. Corticotherapy, 8, 9 intravenous immunoglobulin therapy, 10, 11 and cyclosporine-A 12 have been proposed as treatments; however, there is still no consensus or guidelines about their use, nor satisfactory treatment trials to further evaluate the true impact of such therapies. 4, 8, 13, 14 Bastuji-Garin et al analyzed French patients diagnosed with EN and proposed a score to determine prognosis: the SCORTEN.
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( Table 1) . This score was initially tested in France; however, it is known that the clinical management of EN patients may vary according to the country and hospital they are admitted to. 8 It has been argued that this might render the SCORTEN less reliable when applied to different populations, thus invalidating studies that use it as a tool to predict mortality rates. Despite that, SCORTEN has been validated for its use in the United States of America, 16 Korea, 17 Canada, 18 and China. 19 The purpose of this study was to evaluate the performance of SCORTEN as mortality predictor in acquired immunodeficiency syndrome (AIDS) and to analyze differences in outcomes between AIDS and non-AIDS Brazilian cohorts. Poisson's regression, reported as incidence rate ratio (IRR).
METHODS
The Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) curve was used to verify the predictive capacity of SCORTEN. AUC greater than 0.70 was considered the minimum acceptable accuracy. Besides being tested on the general population, the SCORTEN was tested among AIDS and non-AIDS patients separately.
Statistical analyses were performed using the software Stata ® 14.2 -Statistics/Data analysis, StataCorp LP, Texas, USA.
RESULTS
Sixty-nine patients were included in this study, with age varying between 1 and 74 years. Table 2 The most frequent suspected offending drugs were: sulfonamides, 19 cases (27.5%); penicillins, 10 cases (14.5%), phenytoin, nine cases (13%); carbamazepine and imidazoles, six cases each (8.7%); cephalosporins, diclofenac, metamizole, and phenobarbital, five cases each (7.2%); allopurinol, three cases (4.3%) and tenoxicam, two cases (2.9%). Some drugs were associated with higher mortality rates, (Table 3) . Patients who presented EN triggered by the use of cephalosporins had a rate (IRR) 11.85 higher for death, p=.008, with (20) .514 All patients with ocular sequelae presented SCORTEN<4. This study was conducted in a tertiary level university hospital, in which, in admissions of high complexity cases, the laboratorial parameters needed for SCORTEN calculation are performed as routine (arterial blood gas test, renal function, and serum glucose).
The authors agree that, in all EN cases, the patient should ideally According to the optimal cut-off point obtained by the ROC analysis regarding SCORTEN, of 2.5 for AIDS and 3.5 for non-AIDS and overall, to the endpoint of death related to EN, the following cut-offs for clinical decision of prescribing immunossupressive treatments could be used, SCORTEN>3, or, for a safer option, SCORTEN>2. The SCORTEN scores of highest probability of lethality in our data were 5, 6 and 7, with 100% lethality rate.
All patients with HIV included in this studied fulfilled criteria to AIDS diagnosis, either by AIDS-defining conditions or CD4 count, and were classified as AIDS C2 and AIDS C3. HIV-positive patients without AIDS were not studied because there were none in the period. 
CONCLUSION

